1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Acronyms and Research Methodology
3. Executive Summary: Global Learning Disabilities Treatment Market
4. Market Overview
4.1. Definition
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Learning Disabilities Treatment Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
5.2. Overview of Handwriting Analysis Tools in Learning Disabled Patients & Neuro Degenerative Patients (Parkinson’s, Dementia)
5.3. Diagnosis Tools for Dysgraphia Condition
5.4. Covid-19 Impact Analysis on Industry
6. Global Learning Disabilities Treatment Market Analysis and Forecast, by Disease Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Disease Type, 2017-2031
6.3.1. Auditory Processing Disorder (APD)
6.3.2. Dyscalculia
6.3.3. Dysgraphia
6.3.4. Dyslexia
6.3.5. Language Processing Disorder
6.3.6. Others
6.4. Market Attractiveness Analysis, by Disease Type
7. Global Learning Disabilities Treatment Market Analysis and Forecast, by Treatment
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Treatment, 2017-2031
7.3.1. Assistive Technology Tools (ATT)
7.3.1.1. Personal Listening Devices
7.3.1.2. Sound Field Systems
7.3.1.3. Others
7.3.2. Handwriting Training Tools
7.3.2.1. Portable Word Processors
7.3.2.2. Proofreading Software
7.3.2.3. Others
7.3.3. Therapy
7.3.3.1. Occupational Therapy
7.3.3.2. Speech Therapy
7.3.3.3. Others
7.3.4. Others
7.4. Market Attractiveness Analysis, by Treatment
8. Global Learning Disabilities Treatment Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Homecare
8.3.2. Specialty Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Learning Disabilities Treatment Market Analysis and Forecast, by Region
9.1. Key Findings Outlook
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Learning Disabilities Treatment Market Attractiveness Analysis, by Region
10. North America Learning Disabilities Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Disease Type, 2017-2031
10.2.1. Auditory Processing Disorder (APD)
10.2.2. Dyscalculia
10.2.3. Dysgraphia
10.2.4. Dyslexia
10.2.5. Language Processing Disorder
10.2.6. Others
10.3. Market Value Forecast, by Treatment, 2017-2031
10.3.1. Assistive Technology Tools (ATT)
10.3.1.1. Personal Listening Devices
10.3.1.2. Sound Field Systems
10.3.1.3. Others
10.3.2. Handwriting Training Tools
10.3.2.1. Portable Word Processors
10.3.2.2. Proofreading Software
10.3.2.3. Others
10.3.3. Therapy
10.3.3.1. Occupational Therapy
10.3.3.2. Speech Therapy
10.3.3.3. Others
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Homecare
10.4.2. Specialty Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Disease Type
10.6.2. By Treatment
10.6.3. By End-user
10.6.4. By Country
11. Europe Learning Disabilities Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Disease Type, 2017-2031
11.2.1. Auditory Processing Disorder (APD)
11.2.2. Dyscalculia
11.2.3. Dysgraphia
11.2.4. Dyslexia
11.2.5. Language Processing Disorder
11.2.6. Others
11.3. Market Value Forecast, by Treatment, 2017-2031
11.3.1. Assistive Technology Tools (ATT)
11.3.1.1. Personal Listening Devices
11.3.1.2. Sound Field Systems
11.3.1.3. Others
11.3.2. Handwriting Training Tools
11.3.2.1. Portable Word Processors
11.3.2.2. Proofreading Software
11.3.2.3. Others
11.3.3. Therapy
11.3.3.1. Occupational Therapy
11.3.3.2. Speech Therapy
11.3.3.3. Others
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Homecare
11.4.2. Specialty Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Disease Type
11.6.2. By Treatment
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Learning Disabilities Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Disease Type, 2017-2031
12.2.1. Auditory Processing Disorder (APD)
12.2.2. Dyscalculia
12.2.3. Dysgraphia
12.2.4. Dyslexia
12.2.5. Language Processing Disorder
12.2.6. Others
12.3. Market Value Forecast, by Treatment, 2017-2031
12.3.1. Assistive Technology Tools (ATT)
12.3.1.1. Personal Listening Devices
12.3.1.2. Sound Field Systems
12.3.1.3. Others
12.3.2. Handwriting Training Tools
12.3.2.1. Portable Word Processors
12.3.2.2. Proofreading Software
12.3.2.3. Others
12.3.3. Therapy
12.3.3.1. Occupational Therapy
12.3.3.2. Speech Therapy
12.3.3.3. Others
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Homecare
12.4.2. Specialty Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Disease Type
12.6.2. By Treatment
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Learning Disabilities Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Disease Type, 2017-2031
13.2.1. Auditory Processing Disorder (APD)
13.2.2. Dyscalculia
13.2.3. Dysgraphia
13.2.4. Dyslexia
13.2.5. Language Processing Disorder
13.2.6. Others
13.3. Market Value Forecast, by Treatment, 2017-2031
13.3.1. Assistive Technology Tools (ATT)
13.3.1.1. Personal Listening Devices
13.3.1.2. Sound Field Systems
13.3.1.3. Others
13.3.2. Handwriting Training Tools
13.3.2.1. Portable Word Processors
13.3.2.2. Proofreading Software
13.3.2.3. Others
13.3.3. Therapy
13.3.3.1. Occupational Therapy
13.3.3.2. Speech Therapy
13.3.3.3. Others
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Homecare
13.4.2. Specialty Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Disease Type
13.6.2. By Treatment
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Learning Disabilities Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Disease Type, 2017-2031
14.2.1. Auditory Processing Disorder (APD)
14.2.2. Dyscalculia
14.2.3. Dysgraphia
14.2.4. Dyslexia
14.2.5. Language Processing Disorder
14.2.6. Others
14.3. Market Value Forecast, by Treatment, 2017-2031
14.3.1. Assistive Technology Tools (ATT)
14.3.1.1. Personal Listening Devices
14.3.1.2. Sound Field Systems
14.3.1.3. Others
14.3.2. Handwriting Training Tools
14.3.2.1. Portable Word Processors
14.3.2.2. Proofreading Software
14.3.2.3. Others
14.3.3. Therapy
14.3.3.1. Occupational Therapy
14.3.3.2. Speech Therapy
14.3.3.3. Others
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Homecare
14.4.2. Specialty Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Disease Type
14.6.2. By Treatment
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Sonova Group
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Financial Overview
15.2.1.3. Disease Type Portfolio
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. Origin Instruments Corporation
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Financial Overview
15.2.2.3. Disease Type Portfolio
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
15.2.3. Kurzweil Education
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Financial Overview
15.2.3.3. Disease Type Portfolio
15.2.3.4. Strategic Overview
15.2.3.5. SWOT Analysis
15.2.4. Ginger Software, Inc.
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Financial Overview
15.2.4.3. Disease Type Portfolio
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. Koninklijke Philips N.V.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Financial Overview
15.2.5.3. Disease Type Portfolio
15.2.5.4. Strategic Overview
15.2.5.5. SWOT Analysis
15.2.6. Sight and Sound Technology
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Financial Overview
15.2.6.3. Disease Type Portfolio
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Oticon
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Financial Overview
15.2.7.3. Disease Type Portfolio
15.2.7.4. Strategic Overview
15.2.7.5. SWOT Analysis
15.2.8. Adaptive Tech Solutions, LLC
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Financial Overview
15.2.8.3. Disease Type Portfolio
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9. Speech Therapy Works
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Financial Overview
15.2.9.3. Disease Type Portfolio
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis
15.2.10. Ghotit ltd.
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Financial Overview
15.2.10.3. Disease Type Portfolio
15.2.10.4. Strategic Overview
15.2.10.5. SWOT Analysis
15.2.11. ZYGO-USA
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Financial Overview
15.2.11.3. Disease Type Portfolio
15.2.11.4. Strategic Overview
15.2.11.5. SWOT Analysis
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
